Vera Therapeutics, Inc. (VERA)
33.33
+0.28
(+0.85%)
USD |
NASDAQ |
Sep 24, 16:00
33.32
-0.01
(-0.03%)
After-Hours: 19:59
Vera Therapeutics Enterprise Value : 1.954B for Sept. 23, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 23, 2026 | 1.954B |
| September 22, 2026 | 2.185B |
| September 21, 2026 | 2.041B |
| September 18, 2026 | 2.023B |
| September 17, 2026 | 2.042B |
| September 16, 2026 | 1.862B |
| September 15, 2026 | 1.999B |
| September 14, 2026 | 2.026B |
| September 11, 2026 | 2.098B |
| September 10, 2026 | 1.994B |
| September 09, 2026 | 2.007B |
| September 08, 2026 | 2.115B |
| September 04, 2026 | 2.159B |
| September 03, 2026 | 2.094B |
| September 02, 2026 | 2.142B |
| September 01, 2026 | 2.039B |
| August 31, 2026 | 2.028B |
| August 28, 2026 | 2.036B |
| August 27, 2026 | 2.066B |
| August 26, 2026 | 2.225B |
| August 25, 2026 | 2.115B |
| August 24, 2026 | 2.002B |
| August 21, 2026 | 1.898B |
| August 20, 2026 | 1.825B |
| August 19, 2026 | 1.898B |
| Date | Value |
|---|---|
| August 18, 2026 | 1.899B |
| August 17, 2026 | 1.852B |
| August 14, 2026 | 1.852B |
| August 13, 2026 | 1.655B |
| August 12, 2026 | 1.734B |
| August 11, 2026 | 1.756B |
| August 10, 2026 | 1.848B |
| August 07, 2026 | 1.943B |
| August 06, 2026 | 1.880B |
| August 05, 2026 | 1.760B |
| August 04, 2026 | 1.731B |
| August 03, 2026 | 1.895B |
| July 31, 2026 | 1.886B |
| July 30, 2026 | 1.954B |
| July 29, 2026 | 1.915B |
| July 28, 2026 | 1.974B |
| July 27, 2026 | 2.107B |
| July 24, 2026 | 2.127B |
| July 23, 2026 | 2.192B |
| July 22, 2026 | 2.170B |
| July 21, 2026 | 2.251B |
| July 20, 2026 | 2.238B |
| July 17, 2026 | 2.346B |
| July 16, 2026 | 2.391B |
| July 15, 2026 | 2.634B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Sarepta Therapeutics, Inc. | 2.259B |
| Twist Bioscience Corp. | 9.861B |
| Beam Therapeutics, Inc. | 1.611B |
| Arrowhead Pharmaceuticals, Inc. | 9.225B |
| Oncolytics Biotech, Inc. | 80.65M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -109.47M |
| Total Expenses (Quarterly) | 109.47M |
| EPS Diluted (Quarterly) | -1.524 |
| Earnings Yield | -17.61% |
| Normalized Earnings Yield | -17.61 |